Bernd Voedisch is a seasoned leader in the pharmaceutical industry, currently serving as the Director and Head of Recombinant Protein Discovery at CSL Innovation GmbH since 2023. With over 17 years of experience in Biologics research, Bernd has a strong background in protein production, cell line development, and antibody discovery. Prior roles include Lab Head R&D at Novartis, where they led teams in generating stable mammalian cell lines and innovating technologies for increased research efficiency. Bernd holds a PhD in recombinant antibody technologies and a diploma in Biotechnology.
This person is not in any teams
This person is not in any offices